ROIV
Roivant Sciences Ltd. · Healthcare
Director Keith S Manchester sold $79.7M of Roivant Sciences Ltd.
Sold$79,650,463
$11.55Price
6,896,144Shares
−8%Stake
What ROIV did after the filing
- The stock from Tue, Oct 3 open, $10.41
- −10.7%
- S&P 500, same days
- +5.6%
Measured over 30 trading days, to the Nov 14 close.
Traded Thu, Sep 28. Filed Mon, Oct 2, 5:05 PM ET, after the close. Returns use the Oct 3 open and the Nov 14 close. Not investment advice.